PT  - JOURNAL ARTICLE
AU  - Rheenen, Wouter van
AU  - van der Spek, Rick A.A.
AU  - Bakker, Mark K.
AU  - Vugt, Joke J.F.A. van
AU  - Hop, Paul J.
AU  - Zwamborn, Ramona A.J.
AU  - Klein, Niek de
AU  - Westra, Harm-Jan
AU  - Bakker, Olivier B.
AU  - Deelen, Patrick
AU  - Shireby, Gemma
AU  - Hannon, Eilis
AU  - Moisse, Matthieu
AU  - Baird, Denis
AU  - Restuadi, Restuadi
AU  - Dolzhenko, Egor
AU  - Dekker, Annelot M.
AU  - Gawor, Klara
AU  - Westeneng, Henk-Jan
AU  - Tazelaar, Gijs H.P.
AU  - van Eijk, Kristel R.
AU  - Kooyman, Maarten
AU  - Byrne, Ross P.
AU  - Doherty, Mark
AU  - Heverin, Mark
AU  - Khleifat, Ahmad Al
AU  - Iacoangeli, Alfredo
AU  - Shatunov, Aleksey
AU  - Ticozzi, Nicola
AU  - Cooper-Knock, Johnathan
AU  - Smith, Bradley N.
AU  - Gromicho, Marta
AU  - Chandran, Siddharthan
AU  - Pal, Suvankar
AU  - Morrison, Karen E.
AU  - Shaw, Pamela J.
AU  - Hardy, John
AU  - Orrell, Richard W.
AU  - Sendtner, Michael
AU  - Meyer, Thomas
AU  - Başak, Nazli
AU  - van der Kooi, Anneke J.
AU  - Ratti, Antonia
AU  - Fogh, Isabella
AU  - Gellera, Cinzia
AU  - Lauria Pinter, Giuseppe
AU  - Corti, Stefania
AU  - Cereda, Cristina
AU  - Sproviero, Daisy
AU  - D’Alfonso, Sandra
AU  - Sorarù, Gianni
AU  - Siciliano, Gabriele
AU  - Filosto, Massimiliano
AU  - Padovani, Alessandro
AU  - Chiò, Adriano
AU  - Calvo, Andrea
AU  - Moglia, Cristina
AU  - Brunetti, Maura
AU  - Canosa, Antonio
AU  - Grassano, Maurizio
AU  - Beghi, Ettore
AU  - Pupillo, Elisabetta
AU  - Logroscino, Giancarlo
AU  - Nefussy, Beatrice
AU  - Osmanovic, Alma
AU  - Nordin, Angelica
AU  - Lerner, Yossef
AU  - Zabari, Michal
AU  - Gotkine, Marc
AU  - Baloh, Robert H.
AU  - Bell, Shaughn
AU  - Vourc’h, Patrick
AU  - Corcia, Philippe
AU  - Couratier, Philippe
AU  - Millecamps, Stéphanie
AU  - Meininger, Vincent
AU  - Salachas, François
AU  - Pardina, Jesus S. Mora
AU  - Assialioui, Abdelilah
AU  - Rojas-García, Ricardo
AU  - Dion, Patrick
AU  - Ross, Jay P.
AU  - Ludolph, Albert C.
AU  - Weishaupt, Jochen H.
AU  - Brenner, David
AU  - Freischmidt, Axel
AU  - Bensimon, Gilbert
AU  - Brice, Alexis
AU  - Dürr, Alexandra
AU  - Payan, Christine A.M.
AU  - Saker-Delye, Safa
AU  - Wood, Nicholas
AU  - Topp, Simon
AU  - Rademakers, Rosa
AU  - Tittmann, Lukas
AU  - Lieb, Wolfgang
AU  - Franke, Andre
AU  - Ripke, Stephan
AU  - Braun, Alice
AU  - Kraft, Julia
AU  - Whiteman, David C.
AU  - Olsen, Catherine M.
AU  - Uitterlinden, Andre G.
AU  - Hofman, Albert
AU  - Rietschel, Marcella
AU  - Cichon, Sven
AU  - Nöthen, Markus M.
AU  - Amouyel, Philippe
AU - SLALOM Consortium
AU - PARALS Consortium
AU - SLAGEN Consortium
AU - SLAP Consortium
AU  - Traynor, Bryan
AU  - Singleton, Adrew B.
AU  - Neto, Miguel Mitne
AU  - Cauchi, Ruben J.
AU  - Ophoff, Roel A.
AU  - Wiedau-Pazos, Martina
AU  - Lomen-Hoerth, Catherine
AU  - van Deerlin, Vivianna M.
AU  - Grosskreutz, Julian
AU  - Rödiger, Annekathrin
AU  - Gaur, Nayana
AU  - Jörk, Alexander
AU  - Barthel, Tabea
AU  - Theele, Erik
AU  - Ilse, Benjamin
AU  - Stubendorff, Beatrice
AU  - Witte, Otto W.
AU  - Steinbach, Robert
AU  - Hübner, Christian A.
AU  - Graff, Caroline
AU  - Brylev, Lev
AU  - Fominykh, Vera
AU  - Demeshonok, Vera
AU  - Ataulina, Anastasia
AU  - Rogelj, Boris
AU  - Koritnik, Blaž
AU  - Zidar, Janez
AU  - Ravnik-Glavač, Metka
AU  - Glavač, Damjan
AU  - Stević, Zorica
AU  - Drory, Vivian
AU  - Povedano, Monica
AU  - Blair, Ian P.
AU  - Kiernan, Matthew C.
AU  - Benyamin, Beben
AU  - Henderson, Robert D.
AU  - Furlong, Sarah
AU  - Mathers, Susan
AU  - McCombe, Pamela A.
AU  - Needham, Merrilee
AU  - Ngo, Shyuan T.
AU  - Nicholson, Garth A.
AU  - Pamphlett, Roger
AU  - Rowe, Dominic B.
AU  - Steyn, Frederik J.
AU  - Williams, Kelly L.
AU  - Mather, Karen
AU  - Sachdev, Perminder S.
AU  - Henders, Anjali K.
AU  - Wallace, Leanne
AU  - Carvalho, Mamede de
AU  - Pinto, Susana
AU  - Petri, Susanne
AU  - Osmanovic, Alma
AU  - Weber, Markus
AU  - Rouleau, Guy A.
AU  - Silani, Vincenzo
AU  - Curtis, Charles
AU  - Breen, Gerome
AU  - Glass, Jonathan
AU  - Brown, Robert H.
AU  - Landers, John E.
AU  - Shaw, Christopher E.
AU  - Andersen, Peter M.
AU  - Groen, Ewout J.N.
AU  - Es, Michael A. van
AU  - Pasterkamp, R. Jeroen
AU  - Fan, Dongsheng
AU  - Garton, Fleur C.
AU  - McRae, Allan F.
AU  - Davey Smith, George
AU  - Gaunt, Tom R.
AU  - Eberle, Michael A.
AU  - Mill, Jonathan
AU  - McLaughlin, Russell L.
AU  - Hardiman, Orla
AU  - Kenna, Kevin P.
AU  - Wray, Naomi R.
AU  - Tsai, Ellen
AU  - Runz, Heiko
AU  - Franke, Lude
AU  - Al-Chalabi, Ammar
AU  - Damme, Philip Van
AU  - van den Berg, Leonard H.
AU  - Veldink, Jan H.
TI  - Common and rare variant association analyses in Amyotrophic Lateral Sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
AID  - 10.1101/2021.03.12.21253159
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.03.12.21253159
4099  - http://medrxiv.org/content/early/2021/03/15/2021.03.12.21253159.short
4100  - http://medrxiv.org/content/early/2021/03/15/2021.03.12.21253159.full
AB  - Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a life-time risk of 1 in 350 people and an unmet need for disease-modifying therapies. We conducted a cross-ancestry GWAS in ALS including 29,612 ALS patients and 122,656 controls which identified 15 risk loci in ALS. When combined with 8,953 whole-genome sequenced individuals (6,538 ALS patients, 2,415 controls) and the largest cortex-derived eQTL dataset (MetaBrain), analyses revealed locus-specific genetic architectures in which we prioritized genes either through rare variants, repeat expansions or regulatory effects. ALS associated risk loci were shared with multiple traits within the neurodegenerative spectrum, but with distinct enrichment patterns across brain regions and cell-types. Across environmental and life-style risk factors obtained from literature, Mendelian randomization analyses indicated a causal role for high cholesterol levels. All ALS associated signals combined reveal a role for perturbations in vesicle mediated transport and autophagy, and provide evidence for cell-autonomous disease initiation in glutamatergic neurons.Competing Interest StatementJan Veldink has sponsored research agreements with Biogen Idec. Leonard van den Berg receives personal fees from Cytokinetics, outside the submitted work. Ammar Al-Chalabi has served on scientific advisory boards for Mitsubishi Tanabe Pharma, OrionPharma, Biogen Idec, Lilly, GSK, Apellis, Amylyx, and Wave Therapeutics. Adriano Chio serves on scientific advisory boards for Mitsubishi Tanabe, Roche, Biogen, Denali, and Cytokinetics.Funding StatementW.v.R. is supported by funding provided by the Dutch Research Council (NWO) [VENI scheme grant 09150161810018] and Prinses Beatrix Spierfond (neuromuscular fellowship grant W.F19-03). J.J.F.A.v.V. is funded by Projectnumber W.OR20-08 (The Repeatome as a basis for new treatments of ALS) of the Prinses Beatrix Spierfonds. K.P.K. is supported by funding provided by the Dutch Research Council (NWO) [VIDI grant 91719350]. G.S. was supported by a PhD studentship from the Alzheimers Society. E.H. and J.M. were supported by Medical Research Council (MRC) grant K013807 (awarded to J.M). mQTL SMR data analysis was undertaken using high-performance computing supported by a Medical Research Council (MRC) Clinical Infrastructure award M008924 (awarded to J.M.). French ALS patients of the Pitie-Salpetriere hospital (Paris) have been collected with ARSla funding support. D.B. and T.R.G. received funding from Biogen and UK Medical Research Council (MRC Epidemiology Unit, MC_UU_00011/1 and MC_UU_00011/4) for this project. G.D.S. works in the Medical Research Council Integrative Epidemiology Unit at the University of Bristol MC_UU_00011/1. D.B., E. Tsai and H.R. are employees of Biogen. J.P.R. is funded by the Canadian Institutes of Health Research (FRN 159279). A.A.K is supported by The Motor Neurone Disease Association (MNDA) and NIHR Maudsley Biomedical Research Centre. R.J.P. is supported by the Gravitation program of the Dutch Ministry of Education, Culture, and Science and the Netherlands Organization for Scientific Research (NWO; BRAINSCAPES). Project MinE Belgium was supported by a grant from IWT (# 140935), the ALS Liga Belgium, the National Lottery of Belgium and the KU Leuven Opening the Future Fund (awarded to P.V.D.). P.V.D holds a senior clinical investigatorship of FWO-Vlaanderen and is supported by the E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders, the ALS Liga Belgium and the KU Leuven funds ‘Een Hart voor ALS’, ‘Laeversfonds voor ALS Onderzoek’ and the ‘Valery Perrier Race against ALS Fund’. Several authors of this publication are members of the European Reference Network for Rare Neuromuscular Diseases (ERN-NMD). The authors are pleased to acknowledge the contribution of `Live now` Charity Foundation and Moscow ALS palliative care service for supporting patients with ALS and their families. G.A.R is supported by the Canadian Institutes of Health. Research Australia including its Ice Bucket Challenge Grant. We acknowledge funding from the National Health and Medical Research Council (NHMRC) (1078901, 1083187, 1113400, 1095215, 1121962, 1173790, Enabling Grant #402703). The Older Australian Twins Study (OATS, used for controls) acknowledges funding from the NHMRC/Australian Research Council Strategic Award (401162) and NHMRC (1405325, 1024224, 1025243, 1045325, 1085606, 568969, 1093083). OATS was facilitated through access to Twins Research Australia, a national resource supported by a NHMRC Centre of Research Excellence Grant (1079102). The Sydney Memory and Ageing Study (Sydney MAS, used for controls) has been funded by three NHMRC Program Grants (350833, 568969, and 1093083). We also acknowledge the OATS and Sydney MAS research teams: https://cheba.unsw.edu.au/research-projects/sydney-memory-and-ageing-study; https://cheba.unsw.edu.au/project/older-australian-twins-study. D.C.W. is supported by a Research Fellowship [APP1155413] from the National Health and Medical Research Council of Australia (NHMRC). The QSkin Study is supported by Grants [APP1185416, APP1073898, APP1063061] from the National Health and Medical Research Council of Australia (NHMRC). Several authors of this publication are members of the Netherlands Neuromuscular Center (NL-NMD) and the European Reference Network for rare neuromuscular diseases EURO-NMD. PJS is supported as an 43 NIHR Senior Investigator and by the Sheffield NIHR Biomedical Research Centre. This is in part an EU Joint Programme - Neurodegenerative Disease Research (JPND) project. The project is supported through the following funding organisations under the aegis of JPND - www.jpnd.eu (United Kingdom, Medical Research Council (MR/L501529/1; MR/R024804/1) and Economic and Social Research Council (ES/L008238/1)) and through the Motor Neurone Disease Association. This study represents independent research part funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and Kings College London. A.A-C is supported by an NIHR Senior Investigator Award. Samples used in this research were in part obtained from the UK National DNA Bank for MND Research, funded by the MND Association and the Wellcome Trust. We would like to thank people with MND and their families for their participation in this project. We acknowledge sample management undertaken by Biobanking Solutions funded by the Medical Research Council at the Centre for Integrated Genomic Medical Research, University of Manchester. L.H.v.d.B. reports grants from The Netherlands Organization for Health Research and Development (Vici scheme), grants from The European Community's Health Seventh Framework Programme (grant agreement # 259867 (EuroMOTOR)), grants from The Netherlands Organization for Health Research and Development) the STRENGTH project, funded through the EU Joint Programme - Neurodegenerative Disease Research, JPND). This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement # 772376 - EScORIAL). The collaboration project is co-funded by the PPP Allowance made available by Health∼Holland, Top Sector Life Sciences & Health, to stimulate public-private partnerships. This study was supported by the ALS Foundation Netherlands.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Please see attached .tsv file as requestedAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll summary statistics will be made publicly available in centralized repositories upon publication after peer review.